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Hemoptysis after CardioSEAL device embolization of a venous collateral
after the Fontan operation
Peter Pastuszko, MD,a Jonathan J. Rome, MD,b Marie M. Gleason, MD,b Richard D. Bellah, MD,c
Lisa M. Montenegro, MD,d and J. William Gaynor, MD,a Philadelphia, Pa
Transcatheter closure of septal defects and other vascularstructures in children is a rapidly evolving field with agrowing number of applications for the currently avail-able devices. Despite the widely accepted use of these
closure devices for lesions such as atrial septal defects and patent
ductus arteriosus, their use in the treatment of other defects is
limited. Consequently, little is known about the associated risks
and complications. We present here a case of a delayed compli-
cation of airway erosion from a CardioSEAL device (NMT Med-
ical, Boston, Mass) used to close a large anomalous systemic to
pulmonary venous channel after the Fontan operation.
Clinical Summary
An 18-year-old man with a functional single ventricle presented
with recurrent hemoptysis. He had undergone staged reconstruc-
tive surgery with Fontan completion at 18 months of age. At the
age of 13 years, he was noted to have decreased arterial oxygen
saturations. Cardiac catheterization revealed a large decompress-
ing vein from the superior vena cava to the right pulmonary vein.
Criteria were met for entry into the CardioSEAL High Risk Device
Trial (sponsor: Children’s Hospital, Boston, Mass), and informed
consent was obtained. The vascular channel was closed with a
CardioSEAL device. Five years later, he presented initially with a
cough and subsequently with hemoptysis and recurrent desatura-
tion. Catheterization revealed a left pulmonary artery stenosis, but
no cause for the hemoptysis. Several weeks later he presented with
recurrent hemoptysis. The chest x-ray film was essentially unre-
markable, but a computed tomographic scan revealed erosion of
the CardioSEAL device into the right main-stem bronchus (Figure
1). Bronchoscopy confirmed the erosion of the device through the
lumen of the right upper lobe bronchus, nearly obstructing the right
main-stem bronchus. The device was removed through a right
thoracotomy. There was extensive inflammation and scarring, and
the device was adherent to the right pulmonary artery. Because of
the dense adhesions, it was not possible to obtain proximal control
of the pulmonary artery. Cardiopulmonary bypass support was
used, and a right upper lobectomy with repair of the pulmonary
artery was performed. On follow-up, there has been no hemoptysis
7 months after surgery.
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Figure 1. A, Chest x-ray film shows vascular occlusive device in
right paratracheal area. B, Contrast computed tomography scan
(magnified view) shows vascular occlusive device (short arrow)
with posterior limb (long arrow) eroding into the right main
bronchus.
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Discussion
There is extensive experience with the use of endovascular devices for
closure of intracardiac defects and patent ductus arteriosus. However,
there is little information on the use of these devices for intrapulmonary
occlusions. The CardioSEAL double umbrella device (NMT Medical)
was approved in the United States for closure of muscular ventricular
septal defects in December 2001. Successful use of this device has been
reported in occlusion of a large pulmonary arteriovenous malformation in
an adult patient with hereditary hemorrhagic telangiectasia.1 In our patient
this type of device was used to close an intrapulmonary vein. The
procedure was successful; however, the patient returned 5 years later with
hemoptysis secondary to erosion of the device into the right upper lobe
bronchus. To our knowledge, this is the first reported case of such a
complication. In a recent review of a group of 417 patients who under-
went a device closure of secundum atrial septal defect, Chessa and
associates2 reported an 8.6% incidence of complications. The most com-
mon complication was a device malposition or embolization (3.5%).
Seven patients required surgical intervention after device embolization.
No erosions were reported in this series; however, hemopericardium and
fistula formation have been described after atrial septal defect closure.3,4
The mechanism of erosion is unknown, but it is likely that it is due at least
in part to persistent pressure to the endovascular surface from a con-
strained device. In our case the arms of the CardioSEAL were partially
collapsed in the vascular structure.
The use of stents, coils, and other intravascular devices has grown
dramatically in the last several years. As their use increases, so does
recognition of their limitations and the potential complications of migra-
tion and embolization. Intravascular foreign body migration is a well-
documented phenomenon, particularly for intracardiac missiles and mis-
sile emboli. Previously, foreign body removal was advocated for most
cases; however, a more selective approach has recently been advocated.5
The unstable nature of intravascular foreign bodies continues to be
stressed.
The use of percutaneous interventional techniques for the treatment of
congenital cardiac disease will continue to increase. However, the natural
history of intravascular devices is not well known. Intravascular foreign
objects have a tendency to erode into the surrounding structures and to
migrate. As use of intravascular devices continues to expand, close
follow-up of these patients is necessary.
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Tetralogy of Fallot and hypoplastic aortic arch: A novel perspective
David L. S. Morales, MD, Daniel J. DiBardino, MD, Wesley Vick, MD, Charles D. Fraser, Jr, MD, and
E. Dean McKenzie, MD, Houston, Tex
Tetralogy of Fallot with coarctation of the aorta is a rarediagnosis that is counterintuitive to widely accepted theo-ries of cardiac embryology. This arrangement of tetralogyof Fallot (TOF) with a left-sided obstructive lesion has
only been reported in the literature in 9 previous patients.1,2 We
describe a unique variant of this unlikely association (TOF and a
hypoplastic aortic arch) and discuss its possible embryology and
morphogenesis.
Clinical Summary
A 4-month-old child, weighing 7 kg, was diagnosed with TOF at
birth. She was placed on beta-blocker therapy and monitored with
oxygen saturations in the low 90s, despite severe right ventricular
outflow tract (RVOT) obstruction (gradient of 64 mm Hg). Physical
examination revealed the following blood pressures: right arm 83/40
mm Hg, left arm 89/39 mm Hg, and right leg 82/38 mm Hg, and a
slight decrease in lower extremity pulses. A follow-up echocardio-
gram at 3 months revealed a large ascending aorta and a concern for
aortic coarctation. Subsequent cardiac magnetic resonance imaging
demonstrated TOF and a high right aortic arch with tubular hypopla-
sia and a small descending aorta with diastolic runoff (Figure 1). The
narrowest segment (0.25 cm) was the distal arch between the right
common carotid and right subclavian arteries.
At operation, there was an anterior malrotation of the dilated
ascending aorta, a right aortic arch with mirror image branching,
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